---
title: "Publications"
---

Full publication list available on [Google Scholar](https://scholar.google.ca/citations?user=iWPPB7AAAAAJ&hl) and [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=richer+l&sort=date).

---

### 2026

Bertagnolli J, Dukelow SP, Smith DJ, Richer L, Benson BW. The Clinical Utility of a Novel Multimodal Assessment Battery for Acute Sport-Related Concussion. *Clin J Sport Med*. 2026. [DOI](https://doi.org/10.1097/JSM.0000000000001402)

### 2025

Sicard V, Irani T, Ledoux AA, et al. Prevalence of Orthostatic Autonomic Dysregulation in Pediatric Concussion. *JAMA Netw Open*. 2025;8(7):e2522309. [DOI](https://doi.org/10.1001/jamanetworkopen.2025.22309)

Doshi RN, Ip JE, Defaye P, et al. Dual-Chamber Leadless Pacemaker Implant Procedural Outcomes: Insights from the AVEIR DR i2i Study. *Heart Rhythm*. 2025;22(9):2391-2400. [DOI](https://doi.org/10.1016/j.hrthm.2025.03.1941)

Nguyen PU, Luu H, So H, et al. The Healthcare Cost of Migraine: A Retrospective Cohort Study from Alberta, Canada. *Can J Neurol Sci*. 2025;1-11. [DOI](https://doi.org/10.1017/cjn.2025.40)

Balcom EF, McCombe JA, Kate MP, et al. Inequities in the Use of Disease-Modifying Therapy Among Adults Living With Multiple Sclerosis in Urban and Rural Areas in Alberta, Canada. *Neurology*. 2025;104(3):e210251. [DOI](https://doi.org/10.1212/WNL.0000000000210251)

Satkunam L, Dukelow SP, Yu J, et al. Poststroke Care Pathways and Spasticity Treatment: A Retrospective Study in Alberta. *Can J Neurol Sci*. 2025;52(1):75-84. [DOI](https://doi.org/10.1017/cjn.2024.42)

### 2024

McCombe JA, Smyth P, Kate M, et al. Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta. *Can J Neurol Sci*. 2024;1-12. [DOI](https://doi.org/10.1017/cjn.2024.288)

Navarri X, Robertson DN, Charfi I, et al. Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence. *J Neurosci*. 2024;44(41). [DOI](https://doi.org/10.1523/JNEUROSCI.2256-23.2024)

Lau RS, Boesen ME, Richer L, Hill MD. Siloed Mentality, Health System Suboptimization and the Healthcare Symphony: A Canadian Perspective. *Health Res Policy Syst*. 2024;22(1):87. [DOI](https://doi.org/10.1186/s12961-024-01168-w)

Khoramjoo M, Wang K, Srinivasan K, et al. Plasma Taurine Level Is Linked to Symptom Burden and Clinical Outcomes in Post-COVID Condition. *PLoS One*. 2024;19(6):e0304522. [DOI](https://doi.org/10.1371/journal.pone.0304522)

Balcom EF, McCombe JA, Kate M, et al. Geographical Variation in Medication and Health Resource Use in Multiple Sclerosis. *Can J Neurol Sci*. 2024;1-9. [DOI](https://doi.org/10.1017/cjn.2024.54)

Dubois C, Fernandes H, Lin M, et al. Benzodiazepine Use in Medical Cannabis Authorization Adult Patients from 2013 to 2021: Alberta, Canada. *BMC Public Health*. 2024;24(1):859. [DOI](https://doi.org/10.1186/s12889-024-18356-6)

Skow RJ, Foulkes SJ, Seres P, et al. Effect of Lower Body Negative Pressure on Cardiac and Cerebral Function in POTS. *Physiol Rep*. 2024;12(6):e15979. [DOI](https://doi.org/10.14814/phy2.15979)

Balcom EF, Smyth P, Kate M, et al. Disease-Modifying Therapy Use and Health Resource Utilisation Associated with Multiple Sclerosis over Time. *J Neurol Sci*. 2024;458:122913. [DOI](https://doi.org/10.1016/j.jns.2024.122913)

Richer L, Craig W, Linsdell M, Tang K, Zemek R. Autonomic Cardioregulatory Function Does Not Correlate with Symptom Improvement after Concussion in Children and Adolescents. *J Neurotrauma*. 2024;41(1-2):161-170. [DOI](https://doi.org/10.1089/neu.2023.0113)

### 2023

Tsze DS, Kuppermann N, Casper TC, et al. Stratification of Risk for Emergent Intracranial Abnormalities in Children with Headaches. *BMJ Open*. 2023;13(11):e079040. [DOI](https://doi.org/10.1136/bmjopen-2023-079040)

Richer L, Luu H, Martins KJB, et al. Trajectory of Health Care Resources among Adults Stopping or Reducing Botulinum Toxin for Chronic Migraine in Alberta. *Headache*. 2023;63(9):1285-1294. [DOI](https://doi.org/10.1111/head.14613)

Stickland MK, Martins KJB, Sharpe H, et al. Medication Use of Canadians. *BMJ Open Respir Res*. 2023. [DOI](https://doi.org/10.1136/bmjresp-2023-002083)

Ganesh A, Rosentreter RE, Chen Y, et al. Patient-Reported Outcomes of Neurologic and Neuropsychiatric Symptoms in Mild COVID-19. *CMAJ Open*. 2023;11(4):E696-E705. [DOI](https://doi.org/10.9778/cmajo.20220248)

Sevcik B, Lobay K, Luu H, et al. Analgesic Use among Adults with a Trauma-Related Emergency Department Visit. *Pain Ther*. 2023;12(4):1039-1053. [DOI](https://doi.org/10.1007/s40122-023-00521-1)

Richer LP, Tan Q, Butler MG, et al. Evaluation of Autonomic Nervous System Dysfunction in Childhood Obesity and Prader-Willi Syndrome. *Int J Mol Sci*. 2023;24(9). [DOI](https://doi.org/10.3390/ijms24098013)

Mitja O, Reis G, Boulware DR, et al. Hydroxychloroquine for Treatment of Non-Hospitalized Adults with COVID-19: A Meta-Analysis of Individual Participant Data. *Clin Transl Sci*. 2023;16(3):524-535. [DOI](https://doi.org/10.1111/cts.13468)

### 2022

Ritchie B, Martins KJB, Tran DT, Blain H, Richer L, Klarenbach SW. Economic Impact of Self-Administered Subcutaneous versus Clinic-Administered Intravenous Immunoglobulin G. *Allergy Asthma Clin Immunol*. 2022;18(1):99. [DOI](https://doi.org/10.1186/s13223-022-00735-6)

Chue P, Wong KO, Klarenbach S, et al. Health Resource Utilization, Costs, and Community Treatment Order Status before and after the Initiation of Second-Generation Long-Acting Injectable Antipsychotics in Patients with Schizophrenia in Alberta. *Eur Psychiatry*. 2022. [DOI](https://doi.org/10.1192/j.eurpsy.2022.326)

Ledoux A, Tang K, Freedman SB, et al. Early Analgesic Administration and Headache Presence 7 Days Post-Concussion in Children. *CJEM*. 2022;24(8):876-884. [DOI](https://doi.org/10.1007/s43678-022-00367-0)

Lim RK, Rosentreter R, Chen Y, et al. Quality of Life, Respiratory Symptoms, and Health Care Utilization 1 Year Following Outpatient Management of COVID-19. *Sci Rep*. 2022;12(1):12988. [DOI](https://doi.org/10.1038/s41598-022-17243-7)

Wong KO, Klarenbach SW, Martins KJB, et al. Health Resource Utilization and Cost before versus after Initiation of Second-Generation Long-Acting Injectable Antipsychotics among Adults with Schizophrenia in Alberta. *BMC Psychiatry*. 2022;22(1):444. [DOI](https://doi.org/10.1186/s12888-022-04075-y)

Richer LP, Ali S, Johnson DW, Rosychuk RJ, Newton AS, Rowe BH. A Randomized Trial of Ketorolac and Metoclopramide for Migraine in the Emergency Department. *Headache*. 2022;62(6):681-689. [DOI](https://doi.org/10.1111/head.14307)

Gillis C, Fenton TR, Gramlich L, et al. Malnutrition Modifies the Response to Multimodal Prehabilitation. *Appl Physiol Nutr Metab*. 2022;47(2):141-150. [DOI](https://doi.org/10.1139/apnm-2021-0299)

Richer L, Wong KO, Martins KJB, et al. Characteristics of Adults with Migraine in Alberta: A Population-Based Study. *Can J Neurol Sci*. 2022;49(2):239-248. [DOI](https://doi.org/10.1017/cjn.2021.68)

### 2021

Ali S, Hopkin G, Poonai N, et al. A Novel Preference-Informed Complementary Trial (PICT) Design. *Trials*. 2021;22(1):206. [DOI](https://doi.org/10.1186/s13063-021-05164-1)

Ng C, Rapoport A, Rajapakse T, et al. The Pediatric Neuroirritability Management Protocol at the Stollery Children's Hospital. *Can J Neurol Sci*. 2021. [DOI](https://doi.org/10.1017/cjn.2021.398)

Rajapakse T, Bakal J, Mailo J, et al. Use of Health Care Resources by Pediatric Headache Patients: A Population-Based Cohort Study in Alberta. *Can J Neurol Sci*. 2021. [DOI](https://doi.org/10.1017/cjn.2021.273)

Lee C, Lin M, Martins KJB, et al. Opioid Use in Medical Cannabis Authorization Adult Patients from 2013 to 2018: Alberta. *BMC Public Health*. 2021;21(1):843. [DOI](https://doi.org/10.1186/s12889-021-10867-w)

Gillis C, Richer L, Fenton TR, et al. Colorectal Cancer Patients with Malnutrition Suffer Poor Physical and Mental Health before Surgery. *Surgery*. 2021;170(3):841-847. [DOI](https://doi.org/10.1016/j.surg.2021.04.003)

Yaworski AM, Yager JY, Richer L, et al. Improved Care and Management at a Paediatric Rapid Access Neurology Clinic. *J Paediatr Child Health*. 2021;57(6):908-912. [DOI](https://doi.org/10.1111/jpc.15352)

Schwartz I, Boesen ME, Cerchiaro G, et al. Assessing Hydroxychloroquine as Outpatient Treatment of COVID-19. *CMAJ Open*. 2021;9(2):E693-E702. [DOI](https://doi.org/10.9778/cmajo.20210069)

### 2020

Ali S, Rajagopal M, Klassen T, et al. Study Protocol for Two Complementary Trials of Non-Steroidal or Opioid Analgesia Use for Children Aged 6 to 17 Years with Musculoskeletal Injuries (the No OUCH Study). *BMJ Open*. 2020;10(6):e035177. [DOI](https://doi.org/10.1136/bmjopen-2019-035177)

Barlow KM, Brooks BL, Esser MJ, et al. Efficacy of Melatonin in Children with Postconcussive Symptoms. *Pediatrics*. 2020;145(4). [DOI](https://doi.org/10.1542/peds.2019-2812)

Tsze DS, Cruz AT, Mistry RD, et al. Interobserver Agreement in Assessment of Clinical Findings in Children with Headaches. *J Pediatr*. 2020;221:207-214. [DOI](https://doi.org/10.1016/j.jpeds.2020.02.018)

Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS). *Can J Cardiol*. 2020;36(3):357-372. [DOI](https://doi.org/10.1016/j.cjca.2019.12.024)

### 2019

Kelly LE, Richer L, Ali S, et al. Innovative Approaches to Investigator-Initiated Multicentre Paediatric Clinical Trials in Canada. *BMJ Open*. 2019;9(6):e029024. [DOI](https://doi.org/10.1136/bmjopen-2019-029024)

Akpinar I, Ohinmaa A, Thording L, et al. The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta. *PharmacoEconomics Open*. 2019;3(4):591-597. [DOI](https://doi.org/10.1007/s41669-019-0137-0)

Shin J, Syme C, Wang D, et al. Novel Genetic Locus of Visceral Fat and Systemic Inflammation. *J Clin Endocrinol Metab*. 2019;104(9):3735-3742. [DOI](https://doi.org/10.1210/jc.2018-02656)

Rajapakse T, Mathieu E, Linsdell M, et al. Alterations in Brain MRI in Migraine. *Can J Neurol Sci*. 2019. [DOI](https://doi.org/10.1017/cjn.2019.93)

Yeates KO, Tang K, Barrowman N, et al. Derivation and Initial Validation of Clinical Phenotypes of Children with Concussion in the Emergency Department. *J Neurotrauma*. 2019;36(11):1758-1767. [DOI](https://doi.org/10.1089/neu.2018.6009)

### 2018

Bresee N, Aglipay M, Dubrovsky AS, et al. No Association between Metoclopramide Treatment in the Emergency Department and Reduced Risk of Post-Concussion Headache. *Am J Emerg Med*. 2018;36(12):2225-2231. [DOI](https://doi.org/10.1016/j.ajem.2018.04.007)

Orr SL, Richer L, Barrowman N, Zemek R. Oral Dexamethasone for the Prevention of Acute Migraine Recurrence in Pediatric Patients Presenting to the Emergency Department with Migraine. *Cephalalgia Reports*. 2018. [DOI](https://doi.org/10.1177/2515816318804158)

### 2017

Tran DT, Akpinar I, Fedorak R, et al. The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials. *J Pharm Pharm Sci*. 2017;20(1):407-414. [DOI](https://doi.org/10.18433/J3DH0V)

Raun N, Mailo J, Spinelli E, et al. Quantitative Phenotypic and Network Analysis of 1q44 Microdeletion. *Am J Med Genet A*. 2017;173(4):972-977. [DOI](https://doi.org/10.1002/ajmg.a.38139)

Orsso CE, Mackenzie M, Alberga AS, et al. MRI to Characterize Abnormal Body Composition in Prader-Willi Syndrome. *Metabolism*. 2017;69:67-75. [DOI](https://doi.org/10.1016/j.metabol.2017.01.020)

### 2016

Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the Acute Treatment of Migraine in Children and Adolescents. *Cochrane Database Syst Rev*. 2016;4(4):CD005220. [DOI](https://doi.org/10.1002/14651858.CD005220.pub2)

Markova D, Richer L, Pangelinan M, et al. Age- and Sex-Related Variations in Vocal-Tract Morphology and Voice Acoustics during Adolescence. *Horm Behav*. 2016;81:84-96. [DOI](https://doi.org/10.1016/j.yhbeh.2016.03.001)

Zemek R, Barrowman N, Freedman SB, et al. Clinical Risk Score for Persistent Postconcussion Symptoms among Children with Acute Concussion in the Emergency Department. *JAMA*. 2016;315(10):1014-1025. [DOI](https://doi.org/10.1001/jama.2016.1203)

### 2015

French L, Gray C, Leonard G, et al. Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence. *JAMA Psychiatry*. 2015;72(10):1002-1011. [DOI](https://doi.org/10.1001/jamapsychiatry.2015.1131)

Hansen G, Joffe AR, Bowman SM, Richer L. Nonconvulsive Seizures and Status Epilepticus in Pediatric Head Trauma. *SAGE Open Med*. 2015;3. [DOI](https://doi.org/10.1177/2050312115573817)

VanderPluym J, Richer L. Tic versus TAC: Differentiating the Trigeminal Autonomic Cephalalgias. *Curr Pain Headache Rep*. 2015;19(2):473. [DOI](https://doi.org/10.1007/s11916-014-0473-9)

Rowe BH, Richer L. Improving Migraine Headache Management in Emergency Departments. *Cephalalgia*. 2015;35(4):289-290. [DOI](https://doi.org/10.1177/0333102414539056)

### 2014

Richer L, Craig W, Rowe B. Randomized Controlled Trial of Treatment Expectation and Intravenous Fluid in Pediatric Migraine. *Headache*. 2014;54(9):1496-1505. [DOI](https://doi.org/10.1111/head.12443)

Barlow KM, Brooks BL, MacMaster FP, et al. A Double-Blind, Placebo-Controlled Trial of Melatonin for Post-Concussion Syndrome. *Trials*. 2014;15:271. [DOI](https://doi.org/10.1186/1745-6215-15-271)

Jacob FD, Kanigan A, Richer L, El Hakim H. Unilateral Mobius Syndrome. *Int J Pediatr Otorhinolaryngol*. 2014;78(8):1228-1231. [DOI](https://doi.org/10.1016/j.ijporl.2014.05.036)

Scott O, Richer L, Forbes K, et al. Anti-NMDA Receptor Encephalitis. *J Child Neurol*. 2014;29(5):691-694. [DOI](https://doi.org/10.1177/0883073813501875)

### 2013

Zemek R, Osmond MH, Barrowman N, et al. Predicting and Preventing Postconcussive Problems in Paediatrics (5P). *BMJ Open*. 2013;3(8):e003550. [DOI](https://doi.org/10.1136/bmjopen-2013-003550)

### 2011

Haqq AM, DeLorey DS, Sharma AM, et al. Autonomic Nervous System Dysfunction in Obesity and Prader-Willi Syndrome. *Clin Obes*. 2011;1(4-6):175-183. [DOI](https://doi.org/10.1111/j.1758-8111.2012.00032.x)

Richer LP, Dower NA, Leonard N, Chan AKJ, Robertson CMT. Familial Recurrence of Cerebral Palsy with Multiple Risk Factors. *Case Rep Pediatr*. 2011;2011:307857. [DOI](https://doi.org/10.1155/2011/307857)

### 2010

Richer LP, Laycock K, Millar K, et al. Treatment of Children with Migraine in Emergency Departments: National Practice Variation Study. *Pediatrics*. 2010;126(1):e150-e155. [DOI](https://doi.org/10.1542/peds.2009-2337)

### 2008

Ramaswamy V, Mehta V, Bauman M, Richer L, Massicotte P, Yager JY. Decompressive Hemicraniectomy in Children with Severe Ischemic Stroke. *J Child Neurol*. 2008;23(8):889-894. [DOI](https://doi.org/10.1177/0883073808314960)

### 2007

Richer L, Graham L, Klassen T, Rowe B. Emergency Department Management of Acute Migraine in Children in Canada. *Headache*. 2007;47(5):703-710. [DOI](https://doi.org/10.1111/j.1526-4610.2007.00782.x)

### 2006

Huntsman RJ, Sinclair DB, Richer LP. Tuberous Sclerosis with Open Lipped Schizencephaly. *Pediatr Neurol*. 2006;34(3):231-234. [DOI](https://doi.org/10.1016/j.pediatrneurol.2005.08.012)

### 2005

Ramaswamy V, Sinclair DB, Wheatley BM, Richer L, Snyder T. Epilepsia Partialis Continua. *Pediatr Neurol*. 2005;32(5):341-345. [DOI](https://doi.org/10.1016/j.pediatrneurol.2005.01.001)

Richer LP, Sinclair DB, Bhargava R. Neuroimaging Features of ADEM in Childhood. *Pediatr Neurol*. 2005;32(1):30-36. [DOI](https://doi.org/10.1016/j.pediatrneurol.2004.07.004)

### 2003

Moyse R, Richer L, Vaudry W. An Adolescent with a Progressive Movement Disorder. *Clin Infect Dis*. 2003;36(9):1155-1156. [DOI](https://doi.org/10.1086/368316)

### 2002

Richer LP, Shevell MI, Stewart J, Poulin C. Pediatric Meralgia Paresthetica. *Pediatr Neurol*. 2002. [DOI](https://doi.org/10.1016/s0887-8994(01)00397-6)

Richer LP, Shevell MI, Rosenblatt BR. Epileptiform Abnormalities in Children with Attention-Deficit-Hyperactivity Disorder. *Pediatr Neurol*. 2002. [DOI](https://doi.org/10.1016/s0887-8994(01)00370-8)

### 2001

Richer LP, Shevell MI, Miller SP. Diagnostic Profile of Neonatal Hypotonia: An 11-Year Study. *Pediatr Neurol*. 2001. [DOI](https://doi.org/10.1016/s0887-8994(01)00277-6)
